Strategic Decision Making
Jamey explains how decisions on capital allocation are driven by risk assessment, market size, competition, and timing. By de-risking certain areas and focusing on high-opportunity markets like respiratory vaccines, the company aims to become a sustainable multi-drug player in the biotech industry.In this clip
From this podcast
Odd Lots
Moderna's CFO on How to Allocate Capital in Big Pharma
Related Questions